Skip to main content
Journal cover image

Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation.

Publication ,  Journal Article
Yang, D; Newcomb, R; Kavanaugh, AR; Khalil, D; Greer, JA; Chen, Y-B; DeFilipp, Z; Temel, J; Lee, SJ; LeBlanc, TW; El-Jawahri, A
Published in: Contemp Clin Trials
March 2024

BACKGROUND: Patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT) commonly experience debilitating physical and psychological symptoms during a 3-4-week-hospitalization. During hospitalization, caregivers (i.e., family and friends) also endure immense emotional stress as they witness their loved one struggle with HSCT toxicities. Yet interventions to improve quality of life (QOL) and reduce psychological distress during HSCT are limited. METHODS: We are conducting a multi-site randomized controlled trial of inpatient integrated palliative and transplant care versus usual care in 360 patients hospitalized for HSCT and their caregivers at three academic centers. Intervention participants meet with a palliative care clinician at least twice weekly during the HSCT hospitalization to address their physical and psychological symptoms. Patients assigned to usual care receive all supportive care measures provided by the HSCT team and could be seen by palliative care upon request. We assess patient QOL (Functional Assessment of Cancer Therapy (FACT) - Bone Marrow Transplant), depression and anxiety symptoms (Hospital Anxiety and Depression Scale), post-traumatic stress (PTSD) symptoms (PTSD checklist), symptom burden (Edmonton Symptom Assessment Scale), and fatigue (FACT-Fatigue) as well as caregiver-reported outcomes at baseline, 2 weeks, 3-months, 6-months, and 12-months post-HSCT. The primary endpoint is to compare QOL at week-2 during HSCT hospitalization between the two groups when patients typically experience their QOL nadir during HSCT. CONCLUSIONS: This multi-site trial will define the role of palliative care for improving QOL and care for patients with hematologic malignancies undergoing HSCT and their caregivers.

Duke Scholars

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

March 2024

Volume

138

Start / End Page

107460

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Quality of Life
  • Public Health
  • Palliative Care
  • Multicenter Studies as Topic
  • Inpatients
  • Humans
  • Hospitalization
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yang, D., Newcomb, R., Kavanaugh, A. R., Khalil, D., Greer, J. A., Chen, Y.-B., … El-Jawahri, A. (2024). Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. Contemp Clin Trials, 138, 107460. https://doi.org/10.1016/j.cct.2024.107460
Yang, Daniel, Richard Newcomb, Alison R. Kavanaugh, Dania Khalil, Joseph A. Greer, Yi-Bin Chen, Zachariah DeFilipp, et al. “Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation.Contemp Clin Trials 138 (March 2024): 107460. https://doi.org/10.1016/j.cct.2024.107460.
Yang D, Newcomb R, Kavanaugh AR, Khalil D, Greer JA, Chen Y-B, et al. Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. Contemp Clin Trials. 2024 Mar;138:107460.
Yang, Daniel, et al. “Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation.Contemp Clin Trials, vol. 138, Mar. 2024, p. 107460. Pubmed, doi:10.1016/j.cct.2024.107460.
Yang D, Newcomb R, Kavanaugh AR, Khalil D, Greer JA, Chen Y-B, DeFilipp Z, Temel J, Lee SJ, LeBlanc TW, El-Jawahri A. Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. Contemp Clin Trials. 2024 Mar;138:107460.
Journal cover image

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

March 2024

Volume

138

Start / End Page

107460

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Quality of Life
  • Public Health
  • Palliative Care
  • Multicenter Studies as Topic
  • Inpatients
  • Humans
  • Hospitalization
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Neoplasms